President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting Oct. 1 unless the pharmaceutical company is building a ...
WASHINGTON, DC - JANUARY 31: President Donald Trump holds up an executive order. Trump spoke to reporters about tariffs against China, Canada and Mexico. He has threatened to impose unprecedented ...
The U.S. will impose a 100% tariff on "all any branded or patented Pharmaceutical Product" entering the country from Oct. 1. The measure will not apply to companies building drug manufacturing plants ...
Cyprus Mail on MSN
Marco Pharma International’s vision for 2045: Expanding impact without compromising principles
What does success look like in 2045 for a family-run natural medicine company that refuses to cut corners?Isaac Conyers IV thinks about that question often.The Director of Operations at Marco Pharma ...
The National Organization for Medicines (EOF) is recalling batches of three pharmaceutical products. Details of the ...
In 2025, the search for innovative pharmaceutical compounds with adaptive performance properties is accelerating. Among the many contenders, Healthletic has positioned itself prominently in the ...
StockStory.org on MSN
Pharmaceuticals stocks Q4 highlights: Ocular Therapeutix (NASDAQ:OCUL)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
In 2025, U.S. had a $112 billion pharmaceutical trade deficit, largely with Ireland and Switzerland. Trump suggested imposing 100% tariffs on certain pharmaceutical imports to reduce this deficit.
The last few years have marked a turning point for the pharmaceutical logistics industry. | Pharma logistics are evolving and Frontier Scientific Solutions leads the way with a more reliable, ...
When nearly 20 years ago, the Food and Drug Administration (FDA) issued a new rule 1 that pharmaceutical manufacturers must include a linear bar code on all immediate drug packages that included each ...
NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results